Henderson John T. - 14 Feb 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John Faurescu, attorney-in-fact for Dr. Henderson
Issuer symbol
CYTK
Transactions as of
14 Feb 2024
Net transactions value
-$360,200
Form type
4
Filing time
14 Feb 2024, 16:04:11 UTC
Previous filing
12 Jan 2024
Next filing
25 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $22,200 +5,000 +12% $4.44* 47,632 14 Feb 2024 Direct F1
transaction CYTK Common Stock Sale $382,400 -5,000 -10% $76.48 42,632 14 Feb 2024 Direct F1
holding CYTK Common Stock 83 14 Feb 2024 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -5,000 -100% $0.000000* 0 14 Feb 2024 Common Stock 5,000 $4.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.